Join 30,000+ Independent Readers: Get the FREE Brownstone Journal Newsletter

Pharma

Pharma articles offer sharp opinion and analysis of Big Pharma, exposing industry practices, regulatory capture, profit motives, and their impacts on economics, public policy, public health, social life, trust in medicine, and individual liberty.

We cover critical topics like Pfizer trial irregularities, vaccinology “big lies”, COVID vaccine cardiac risks, industry influence on regulation, ACIP decisions, medical journal failures, vaccine safety debates, and calls for accountability, transparency, and evidence-based reform.

FDA Leadership’s “Blind Spots” Leads to a Surge in Medical Device and Drug Recalls

FDA Leadership’s “Blind Spots” Lead to a Surge in Medical Device and Drug Recalls

SHARE | PRINT | EMAIL

The FDA possesses the legal authority, institutional framework, and technical expertise necessary to solve this problem. What is missing is leadership’s willingness to demand the standards that once defined American drug regulation and legacy records of a low number of recalls.

FDA Leadership’s “Blind Spots” Lead to a Surge in Medical Device and Drug Recalls Continue Reading

Major Journal under Fire for Omitting Pfizer’s Failed Flu Data in Seniors

Major Journal under Fire for Omitting Pfizer’s Failed Flu Data in Seniors

SHARE | PRINT | EMAIL

Unless this system is forced into the open, selective reporting will continue to be standard practice in even the most prestigious journals. And the public will keep receiving a polished marketing story instead of the full scientific truth.

Major Journal under Fire for Omitting Pfizer’s Failed Flu Data in Seniors Continue Reading